_id

690db348ccc777a4e85d0cd2

Ticker

AUTL

Name

Autolus Therapeutics Ltd

Exchange

NASDAQ

Address

The Mediaworks, London, United Kingdom, W12 7FP

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.autolus.com

Description

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Last Close

1.59

Volume

2602857

Current Price

1.61

Change

1.2578616352201268

Last Updated

2025-11-28T12:34:12.890Z

Image

data:image/webp;base64,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

Ipo Date

2018-06-22T00:00:00.000Z

Market Cap

364616288

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.906375

Sentiment Sources

8

Rating

4.8

Target Price

9.5222

Strong Buy

8

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

21194000

Cost Of Revenue

28643000

Gross Profit

-7449000

Operating Expenses

64172000

Operating Income

-71621000

Interest Expense

10520000

Pretax Income

-78586000

Net Income

-79118000

Eps

-0.2972780288387342

Dividends Per Share

-

Shares Outstanding

266143286

Income Tax Expense

532000

EBITDA

-64703000

Operating Margin

-337.9305463810512

Total Other Income Expense Net

-6965000

Cash

86124000

Short Term Investments

281289000

Receivables

91359000

Inventories

27723000

Total Current Assets

514577000

Property Plant Equipment

123476000

Total Assets

661947000

Payables

10967000

Short Term Debt

4828000

Long Term Debt

-

Total Liabilities

396495000

Equity

265452000

Depreciation

595000

Change In Working Capital

40620000

Cash From Operations

-67899000

Capital Expenditures

15520000

Cash From Investing

35547000

Cash From Financing

-1774000

Net Change In Cash

-37710000

PE

-

PB

1.6141814863327457

ROE

-29.805011828880552

ROA

-11.95231642412459

FCF

-83419000

Fcf Percent

-3.935972445031613

Piotroski FScore

1

Health Score

25

Deep Value Investing Score

3

Defensive Investing Score

6

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

1.5

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

1.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

21194000

Quarters > 0 > income Statement > cost Of Revenue

28643000

Quarters > 0 > income Statement > gross Profit

-7449000

Quarters > 0 > income Statement > operating Expenses

64172000

Quarters > 0 > income Statement > operating Income

-71621000

Quarters > 0 > income Statement > interest Expense

10520000

Quarters > 0 > income Statement > pretax Income

-78586000

Quarters > 0 > income Statement > net Income

-79118000

Quarters > 0 > income Statement > eps

-0.2972780288387342

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

266141431

Quarters > 0 > income Statement > income Tax Expense

532000

Quarters > 0 > income Statement > EBITDA

-64703000

Quarters > 0 > income Statement > operating Margin

-337.9305463810512

Quarters > 0 > income Statement > total Other Income Expense Net

-6965000

Quarters > 0 > balance Sheet > cash

86124000

Quarters > 0 > balance Sheet > short Term Investments

281289000

Quarters > 0 > balance Sheet > receivables

91359000

Quarters > 0 > balance Sheet > inventories

27723000

Quarters > 0 > balance Sheet > total Current Assets

514577000

Quarters > 0 > balance Sheet > property Plant Equipment

123476000

Quarters > 0 > balance Sheet > total Assets

661947000

Quarters > 0 > balance Sheet > payables

10967000

Quarters > 0 > balance Sheet > short Term Debt

4828000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

396495000

Quarters > 0 > balance Sheet > equity

265452000

Quarters > 0 > cash Flow > net Income

-79115000

Quarters > 0 > cash Flow > depreciation

595000

Quarters > 0 > cash Flow > change In Working Capital

40620000

Quarters > 0 > cash Flow > cash From Operations

-67899000

Quarters > 0 > cash Flow > capital Expenditures

15520000

Quarters > 0 > cash Flow > cash From Investing

35547000

Quarters > 0 > cash Flow > cash From Financing

-1774000

Quarters > 0 > cash Flow > net Change In Cash

-37710000

Quarters > 0 > ratios > PE

-0.2972780288387342

Quarters > 0 > ratios > PB

1.6141814863327457

Quarters > 0 > ratios > ROE

-29.805011828880552

Quarters > 0 > ratios > ROA

-11.95231642412459

Quarters > 0 > ratios > FCF

-83419000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-3.935972445031613

Quarters > 0 > health Score

25

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

20923000

Quarters > 1 > income Statement > cost Of Revenue

24445000

Quarters > 1 > income Statement > gross Profit

-3522000

Quarters > 1 > income Statement > operating Expenses

57695000

Quarters > 1 > income Statement > operating Income

-61217000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-47520000

Quarters > 1 > income Statement > net Income

-47917000

Quarters > 1 > income Statement > eps

-0.18004338302692774

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

266141411

Quarters > 1 > income Statement > income Tax Expense

397000

Quarters > 1 > income Statement > EBITDA

-56906000

Quarters > 1 > income Statement > operating Margin

-292.58232567031496

Quarters > 1 > income Statement > total Other Income Expense Net

13697000

Quarters > 1 > balance Sheet > cash

123825000

Quarters > 1 > balance Sheet > short Term Investments

330454000

Quarters > 1 > balance Sheet > receivables

78592000

Quarters > 1 > balance Sheet > inventories

23943000

Quarters > 1 > balance Sheet > total Current Assets

574250000

Quarters > 1 > balance Sheet > property Plant Equipment

125086000

Quarters > 1 > balance Sheet > total Assets

720981000

Quarters > 1 > balance Sheet > payables

5408000

Quarters > 1 > balance Sheet > short Term Debt

3277000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

374517000

Quarters > 1 > balance Sheet > equity

346464000

Quarters > 1 > cash Flow > net Income

-47920000

Quarters > 1 > cash Flow > depreciation

4311000

Quarters > 1 > cash Flow > change In Working Capital

-22921000

Quarters > 1 > cash Flow > cash From Operations

-72781000

Quarters > 1 > cash Flow > capital Expenditures

7277000

Quarters > 1 > cash Flow > cash From Investing

95915000

Quarters > 1 > cash Flow > cash From Financing

-768000

Quarters > 1 > cash Flow > net Change In Cash

28081000

Quarters > 1 > ratios > PE

-0.18004338302692774

Quarters > 1 > ratios > PB

1.2367451501743327

Quarters > 1 > ratios > ROE

-13.830296942828117

Quarters > 1 > ratios > ROA

-6.646083599983911

Quarters > 1 > ratios > FCF

-80058000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-3.826315537924772

Quarters > 1 > health Score

24

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

8982000

Quarters > 2 > income Statement > cost Of Revenue

17951000

Quarters > 2 > income Statement > gross Profit

-8969000

Quarters > 2 > income Statement > operating Expenses

56268000

Quarters > 2 > income Statement > operating Income

-65237000

Quarters > 2 > income Statement > interest Expense

10143000

Quarters > 2 > income Statement > pretax Income

-67936000

Quarters > 2 > income Statement > net Income

-70161000

Quarters > 2 > income Statement > eps

-0.2636377337295939

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

266126548

Quarters > 2 > income Statement > income Tax Expense

2225000

Quarters > 2 > income Statement > EBITDA

-55516000

Quarters > 2 > income Statement > operating Margin

-726.3081718993543

Quarters > 2 > income Statement > total Other Income Expense Net

-2699000

Quarters > 2 > balance Sheet > cash

95799000

Quarters > 2 > balance Sheet > short Term Investments

420776000

Quarters > 2 > balance Sheet > receivables

14317000

Quarters > 2 > balance Sheet > inventories

14647000

Quarters > 2 > balance Sheet > total Current Assets

615773000

Quarters > 2 > balance Sheet > property Plant Equipment

114220000

Quarters > 2 > balance Sheet > total Assets

746338000

Quarters > 2 > balance Sheet > payables

4457000

Quarters > 2 > balance Sheet > short Term Debt

2974000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

375230000

Quarters > 2 > balance Sheet > equity

371108000

Quarters > 2 > cash Flow > net Income

-70161000

Quarters > 2 > cash Flow > depreciation

2277000

Quarters > 2 > cash Flow > change In Working Capital

-17699000

Quarters > 2 > cash Flow > cash From Operations

-75565000

Quarters > 2 > cash Flow > capital Expenditures

8243000

Quarters > 2 > cash Flow > cash From Investing

-59547000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-131554000

Quarters > 2 > ratios > PE

-0.2636377337295939

Quarters > 2 > ratios > PB

1.1545526970046456

Quarters > 2 > ratios > ROE

-18.905817174515235

Quarters > 2 > ratios > ROA

-9.400700486910758

Quarters > 2 > ratios > FCF

-83808000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-9.330661322645291

Quarters > 2 > health Score

24

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

29000

Quarters > 3 > income Statement > cost Of Revenue

138304000

Quarters > 3 > income Statement > gross Profit

-138275000

Quarters > 3 > income Statement > operating Expenses

103151000

Quarters > 3 > income Statement > operating Income

-241426000

Quarters > 3 > income Statement > interest Expense

30835000

Quarters > 3 > income Statement > pretax Income

-26144000

Quarters > 3 > income Statement > net Income

-27606000

Quarters > 3 > income Statement > eps

-0.1037330767194106

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

266125337

Quarters > 3 > income Statement > income Tax Expense

1462000

Quarters > 3 > income Statement > EBITDA

-73787000

Quarters > 3 > income Statement > operating Margin

-832503.4482758621

Quarters > 3 > income Statement > total Other Income Expense Net

215282000

Quarters > 3 > balance Sheet > cash

227380000

Quarters > 3 > balance Sheet > short Term Investments

360643000

Quarters > 3 > balance Sheet > receivables

48240000

Quarters > 3 > balance Sheet > inventories

4138000

Quarters > 3 > balance Sheet > total Current Assets

660929000

Quarters > 3 > balance Sheet > property Plant Equipment

105051000

Quarters > 3 > balance Sheet > total Assets

782725000

Quarters > 3 > balance Sheet > payables

1969000

Quarters > 3 > balance Sheet > short Term Debt

2998000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

355400000

Quarters > 3 > balance Sheet > equity

427325000

Quarters > 3 > cash Flow > net Income

-27606000

Quarters > 3 > cash Flow > depreciation

2077000

Quarters > 3 > cash Flow > change In Working Capital

-2986000

Quarters > 3 > cash Flow > cash From Operations

-37934000

Quarters > 3 > cash Flow > capital Expenditures

23856000

Quarters > 3 > cash Flow > cash From Investing

-383589000

Quarters > 3 > cash Flow > cash From Financing

30007000

Quarters > 3 > cash Flow > net Change In Cash

-429732000

Quarters > 3 > ratios > PE

-0.1037330767194106

Quarters > 3 > ratios > PB

1.0026602528988475

Quarters > 3 > ratios > ROE

-6.460188381208681

Quarters > 3 > ratios > ROA

-3.526909195439011

Quarters > 3 > ratios > FCF

-61790000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-2130.689655172414

Quarters > 3 > health Score

30

Valuation > metrics > PE

-0.2972780288387342

Valuation > metrics > PB

1.6141814863327457

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-29.805011828880552

Profitability > metrics > ROA

-15.375347129778438

Profitability > metrics > Net Margin

-3.733037652165707

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.493659870711089

Risk > metrics > Interest Coverage

-6.808079847908745

Risk > final Score

3

Risk > verdict

High

Liquidity > metrics > Current Ratio

32.57847420069642

Liquidity > metrics > Quick Ratio

30.8232985121874

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

4

Prev Risks > 1

4

Prev Risks > 2

17

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:15:13.870Z